Polyrizon Ltd. (PLRZ), an Israeli pre-clinical stage biotechnology company, on Tuesday, signed a non-binding memorandum of understanding to acquire up to a 20% stake in a developer of eVTOL, Colugo Systems Ltd., from two shareholders.
The proposed transaction is valued at up to $6 million and may be paid in cash or shares.
The deal is expected to close shortly after certain conditions are met.
Colugo develops electric vertical take-off and landing drone systems serving defense, emergency response and commercial customers, including the Israel Defense Forces.
The MOU will terminate upon written notice by either party or on September 30, if the transaction has not closed by then.
In the pre-market trading, Polyrizon is 4.20% lesser at $13.70 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.